Use of a gonadotropin-releasing hormone agonist in the evaluation of postmenopausal virilization due to ovarian hyperthecosis: A case report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 41, Issue 4, 1996, Pages 259-262

  Koroscil, Thomas M ^a,b   Harter, Steven B ^a,b   Ouweleen, Jennifer ^a,b   Blauer, Keith L ^a,b  

^a WRIGHT PATTERSON AIR FORCE BASE   (United States)

^b Department of Internal Medicine ^*

Author keywords

gonadotropin releasing hormone; ovarian diseases; postmenopause; virilism

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTENEDIONE; CONJUGATED ESTROGEN; CORTICOTROPIN; DEXAMETHASONE; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; HYDROCORTISONE; HYDROXYPROGESTERONE; LEUPRORELIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; OXOSTEROID; SPIRONOLACTONE; STEROID 21 MONOOXYGENASE; TESTOSTERONE; THYROTROPIN;

ADRENAL HYPERPLASIA; ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CASE REPORT; FEMALE; GONADOTROPIN BLOOD LEVEL; HIRSUTISM; HORMONE URINE LEVEL; HUMAN; OVARY DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; VIRILIZATION;

ADRENOCORTICAL HYPERFUNCTION; ANDROGENS; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; ESTROGENS, CONJUGATED (USP); FALLOPIAN TUBES; FEMALE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; HYPERPLASIA; HYSTERECTOMY; LEUPROLIDE; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; OVARIAN DISEASES; OVARIECTOMY; OVARY; POSTMENOPAUSE; PROGESTERONE CONGENERS; VIRILISM;

EID: 0029864054     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Speroff L, Glass RH, Kase NG: Clinical Gynecologic Endocrinology and Infertility. Fourth edition. Baltimore, Williams & Wilkins, 1989
2. Braithwaite SS, Erkman-Balis B, Avila TD: Postmenopausal virilization due to ovarian stromal hyperthecosis. J Clin Endocrinol Metab 1978;46:295-300
3. Van Heyningen C, Macfarlane LA, Diver MJ, et al: Virilization due to ovarian hyperthecosis in a postmenopausal woman. Gynecol Endocrinol 1988;2:331-338
4. Leedman PJ, Bierre AR, Martin FIR: Virilizing nodular ovarian stromal hyperthecosis, diabetes mellitus and insulin resistance in a postmenopausal woman: Case report. Br J Obstet Gynaecol 1989;96:1095-1098
5. Goldman JM, Kapadia LJ: Virilization in a postmenopausal woman due to ovarian stromal hyperthecosis. Postgrad Med J 1991;67:304-306
6. Madiedo G, Tieu TM, Aiman J: Atypical ovarian hyperthecosis in a virilized postmenopausal woman. Am J Clin Pathol 1985;83:101-107
7. Ferriman D, Gallway J: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961:60:1440-1447
8. New MI, Lorenzen F, Lerner AJ, et al: Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data. J Clin Endocrinol Metab 1983;57:320-326
9. Chang RJ, Judd HL: The ovary after menopause. Clin Obstet Gynecol 1981;24:181-191
10. Cummings DC: Menarche, menses, and menopause: A brief review. Cleveland Clin J Med 1990;57:169-175
11. Adashi E: Potential utility of gonadotropin-releasing hormone agonists in the management of ovarian hyperandrogenism. Fertil Steril 1990;53:765-777
12. Steingold KA, Judd HL, Nieberg RK, et al: Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist. Am J Obstet Gynecol 1986;154:1241-1248
13. Abraham GE, Buster JE: Peripheral and ovarian steroids in ovarian hyperthecosis. Obstet Gynecol 1976;47:581-586
14. Nagamani M, Van Dinh T, Kelver ME: Hyperinsulinemia in hyperthecosis of the ovaries. Am J Obstet Gynecol 1986;154:384-389
15. Moghissi E, Ablan F, Horton R: Origin of plasma androstenediol glucuronide in men. J Clin Endocrinol Metab 1984; 59:417-421
16. Pang S, Wang M, Jeffries S, et al: Normal and elevated 3-alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels. J Clin Endocrinol Metab 1992;75:243-248